← Browse by Condition
Medical Condition

neoplasms colon

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05855200 Phase 3
Recruiting

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Enrollment
892 pts
Location
United States, Argen...
Sponsor
GlaxoSmithKline
View Trial →